CoChat

The role of utrophin in the potential therapy of Duchenne muscular dystrophy

Perkins, Kelly J, Davies, Kay E · 2002 · Neuromuscular Disorders

The DOI matches its Crossref record; 121 of the 121 references it cites were found in a registry or an index.

Abstract

Duchenne muscular dystrophy is an X-linked recessive muscle wasting disease caused by the absence of the muscle cytoskeletal protein, dystrophin. Dystrophin is a member of the spectrin superfamily of proteins and is closely related in sequence similarity and functional motifs to three proteins that constitute the dystrophin related protein family, including the autosomal homologue, utrophin. An alternative strategy circumventing many problems associated with somatic gene therapies for Duchenne muscular dystrophy has arisen from the demonstration that utrophin can functionally substitute for dystrophin and its over-expression in muscles of dystrophin-null transgenic mice completely prevents the phenotype arising from dystrophin deficiency. One potential approach to increase utrophin levels in muscle for possible therapeutic purpose in humans is to increase expression of the utrophin gene at a transcriptional level via promoter activation. This has lead to an interest in the identification and manipulation of important regulatory regions and/or molecules that increase the expression of utrophin and their delivery to dystrophin-deficient tissue. As pre-existing cellular mechanisms are utilized, this approach would avoid many problems associated with conventional gene therapies.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0960-8966(02)00087-1

Cites

121 of 121 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Show all 121 references

Research works printed but not linked: 1

  1. Tinsley, 1998, Expression of full-length utrophin prevents muscular dystrophy in mdx mice, Nat Med, 4, 1441, 10.1038/4033 · DOI · Paper page

Cited by

See all 73

Metadata

Authors
Perkins, K. J., & Davies, K. E.
Affiliations
University of Oxford (GB)
Corresponding author
Davies, Kay E
Venue
Neuromuscular Disorders
Publisher
Elsevier BV
Published
2002-10
Volume
12
Pages
S78-S89
ISSN
0960-8966 (ISSN-L)
OpenAlex
W1966945158
Cited by
71
References
120
Citations by year
2026: 3 · 2025: 1 · 2024: 1 · 2023: 3 · 2022: 5 · 2021: 2 · 2020: 4 · 2019: 3 · 2018: 2 · 2017: 1 · 2016: 2 · 2015: 3 · 2014: 4 · 2013: 3 · 2012: 2
FWCI
0.24
Type
journal article
Language
en
Open access
closed
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)
Locations
  • Neuromuscular Disorders (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
  • Health Sciences › Medicine › Genetics (clinical) › Neurogenetic and Muscular Disorders Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
Keywords
utrophin, Duchenne muscular dystrophy, dystrophin, dystrophin-related protein, promoter activation, transcriptional regulation, muscle atrophy
MeSH terms
Animals, Cytoskeletal Proteins, Humans, Membrane Proteins, Muscular Dystrophy, Animal, Promoter Regions, Genetic, Genetic Therapy, Up-Regulation, Dystrophin, Mice, Inbred mdx, Muscular Dystrophy, Duchenne, Utrophin, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The role of utrophin in the potential therapy of Duchenne muscular dystrophy. https://app.cochat.ai/papers/10.1016/s0960-8966(02)00087-1
The paper
Perkins, K. J., & Davies, K. E. (2002). The role of utrophin in the potential therapy of Duchenne muscular dystrophy. Neuromuscular Disorders. https://doi.org/10.1016/s0960-8966(02)00087-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.